Unique ID issued by UMIN | UMIN000029053 |
---|---|
Receipt number | R000033231 |
Scientific Title | Study on body fat reducing effect of dietary supplement -A randomized, double blind, placebo-controlled, parallel group study- |
Date of disclosure of the study information | 2017/09/08 |
Last modified on | 2017/09/08 11:24:42 |
Study on body fat reducing effect of dietary supplement -A randomized, double blind, placebo-controlled, parallel group study-
Study on body fat reducing effect of dietary supplement
Study on body fat reducing effect of dietary supplement -A randomized, double blind, placebo-controlled, parallel group study-
Study on body fat reducing effect of dietary supplement
Asia(except Japan) |
Healthy subject
Not applicable | Adult |
Others
NO
This study aims to evaluate the effect of the dietary supplement on body fat of subject aged 40 to 64 years with slightly high body mass index (BMI: 23 kg/m2 to less than 30 kg/m2).
Efficacy
Confirmatory
Explanatory
Not applicable
Abdominal fat area
Body weight, BMI, body fat percentage
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
2
Prevention
Food |
Intake of dietary supplement for 12 consecutive weeks
Intake of placebo for 12 consecutive weeks
40 | years-old | <= |
65 | years-old | > |
Female
1)Vietnamese women between 40 and 65 years old at the time of obtaining informed consent.
2)BMI between 23 and 30kg/m2.
3)Waist circumference of at least 80cm.
1)The candidate is currently undergoing drug or exercise therapy.
2)The candidate currently has, or has a history of, diabetes, liver disease, kidney disease, heart disease, any disease that affects corticosteroid secretion, and/or any other metabolic disease.
3)There are concerns about the potential for the study foods to induce allergic symptoms in the candidate.
4)The candidate is pregnant, or intends to become pregnant or to breastfeed during the study period.
5)The candidate generally or routinely takes any medication that affects body fat and/or lipid metabolism, including over-the-counter drugs, quasi-drugs, and health foods.
6)The candidate is currently dieting with the aim of reducing body weight.
7)The candidate has participated in any other clinical study within the past 1month.
100
1st name | |
Middle name | |
Last name | Bui Thi Nhung |
National Institute of Nutrition
-
48B-Tang Bat Ho, Hanoi-Vietnam
+84-43971-7090
nhungvnnin@gmail.com
1st name | |
Middle name | |
Last name | Yoshiki Shimizu |
FANCL Corporataion
Research Institute
12-13 Kamishinano, Totsuka-ku, Yokohama, Kanagawa 244-0806, Japan
045-820-3755
shimizu_yoshiki@fancl.co.jp
FANCL Corporation
FANCL Corporation
Profit organization
NO
2017 | Year | 09 | Month | 08 | Day |
Unpublished
Completed
2016 | Year | 02 | Month | 01 | Day |
2016 | Year | 03 | Month | 23 | Day |
2017 | Year | 09 | Month | 08 | Day |
2017 | Year | 09 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033231
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |